Generic Zantac makers halt worldwide distribution after FDA finds possible cancer chemical in drugs
Novartis, a Swiss pharmaceutical company, halted worldwide distribution of its generic version of the popular heartburn medication Zantac after the U.S. Food and Drug Administration found traces of a possible carcinogen in it.